CASP3 and liver cancer: In a study on liver cancer cells, GSP was found to trigger ROS production, decrease matrix-metalloproteinases (MMPs), and increase caspase-3 activity in HepG2 cells (Wang et al., 2020), proving that GSPs may induce ROS production and, consequently, lead to MMP reduction and caspase-3 activation.